Stocksigma LogoStocksigma Logo

Vivanza Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 1,141 (-79.4% YoY | +22.9% QoQ) ■ EBITDA: 24.1 (-60.2% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 2.1 (+102 bps YoY | Loss to Profit QoQ) ■

Vivanza Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Vivanza Biosciences Ltd · Outcome · 07 Nov 2026, 1:13 am

Vivanza Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,141 (-79.4% YoY | +22.9% QoQ) ■ EBITDA: 24.1 (-60.2% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 2.1 (+102 bps YoY | Loss to Profit QoQ) ■ PAT: 13.6 (-75.8% YoY | -7.0% QoQ) ■ EPS (INR): 0.03 (-78.6% YoY | -25.0% QoQ)

Original exchange filing (PDF)

More announcements from Vivanza Biosciences Ltd

All Vivanza Biosciences Ltd announcements